Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–10 of 10 trials
Active filters
Clinical trials found
Published and searchable clinical trials
A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies
NCT07609862
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
NCT07121946
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma ( FL), +18 more
- Locations
-
- City of Hope Duarte, California, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- Memorial Sloan Kettering Cancer Center - Bergen New York, United States
NCT07154823
- Conditions
- Acute Myeloid Leukaemia (AML), Follicular Lymphoma ( FL), Hematologic Diseases, +15 more
- Locations
-
- University of Iowa Hospital and Clinics Iowa City, Iowa, United States
- The Center for Cancer and Blood Disorders Bethesda, Maryland, United States
- Washington University in St. Louis St Louis, Missouri, United States
- Cancer Care Specialists of Reno Reno, Nevada, United States
NCT06703892
- Conditions
- Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, Follicular Lymphoma ( FL), +13 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)
NCT07502118
- Conditions
- Burkitt Lymphoma, Cytokine Release Syndrome, DNA Virus Infections, +29 more
- Locations
-
- Ankara Bilkent City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
- Ankara Etlik City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
- Hacettepe University Faculty of Medicine - Department of Internal Medicine, Division of Hematology Ankara, Turkey (Türkiye)
- University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Ankara, Turkey (Türkiye)
Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma
NCT07077512
- Conditions
- Follicular Lymphoma ( FL), Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Sun Yat-sen Universitiy Cancer Center Guangzhou, China
- Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou, China
- Guangzhou overseas Chinese hospital Guangzhou, China
NCT06959732
- Conditions
- Follicular Lymphoma ( FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
NCT07719855
- Conditions
- Follicular Lymphoma ( FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Ruijin Hosiptal Shanghai, Shanghai Municipality, China
Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors
NCT07592481
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +34 more
- Locations
-
Not specified
Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma
NCT07168291
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma (DLBCL), +18 more
- Locations
-
- First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China